To date, the majority of
|
|
- Michael Greer
- 6 years ago
- Views:
Transcription
1 B i o P r o c e s s TECHNICAL Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal Mario Metzger, Anja Gerster, Marcus Peiker, Sabine Faust, Alexander Faude, Sybille Ebert, Sophie Winterfeld, Nicole Mang, and Dethardt Müller For Personal Use Only To date, the majority of recombinant monoclonal antibodies (MAbs) have been produced by mammalian cells. During such production processes, the potential risk of entrained viruses must be critically considered (1). Contamination can arise from animal cell lines or from adventitious viruses introduced during manufacturing. To ensure the viral safety of biotechnology products, companies can take four complementary approaches (2, 3): Using animal-component free raw materials wherever possible Virus testing of master cell banks Virus testing of unprocessed harvest Performing downscale virus validation studies on selected process steps to demonstrate the capacity of the process to remove and inactivate viruses. Product Focus: Monoclonal antibodies and other recombinant proteins Process Focus: Downstream Processing Who Should Read: Process development and manufacturing Keywords: Viral clearance, adsorptive depth filtration, charged filters, MVM, X-MuLV Level: Intermediate In most antibody-purification processes, the first viral clearance step is a low-ph inactivation (ph <4) conducted after protein A affinity capture chromatography. Precipitation of impurities often occurs in this lowph treatment and subsequent conditioning, and filtration is required afterward before further processing in chromatographic polishing steps. Depth filters are commonly used (Figure 1). Many processors apply charged depth filters to make better use of that filtration step. Charged depth filtration is a scalable, well-characterized unit operation commonly used in bloodplasma fractionation processes, providing viral log clearance of 6 LRV (log 10 reduction value) (7, 8). Previous investigations of antibody 3M ( processes have demonstrated the ability of positively charged depth filters to reduce host-cell proteins (HCPs) and DNA (4) and to effectively remove viruses (1, 5, 6). Some investigators postulate that the virus retention can be attributed to anionic adsorptive effects of mammalian viruses on positively charged filter media (5). Such recommended model viruses for downscale virus validation studies as xenotropic murine leukemia virus (X-MuLV) and minute virus of mice (MVM) have a negative net charge at neutral or basic ph. Consequently, they bind to the positively charged surface of depth filters. Our objective was to demonstrate the capabilities of three different adsorptive filters to remove viral contamination under typical process
2 Figure 1: Antibody purification process with adsorptive depth filtration as a viral clearance step orthogonal to low-ph inactivation and virus filtration; the additional virus removal step in this process presumably enables replacement of anion-exchange chromatography as a polishing step while maintaining the virus safety of the process. Thus, a two-column purification process could be implemented (4, 9). Clarified Cell Culture Harvest Table 1: Overview of used filter types and process parameters used EXT EXT Emphaze AEX FNW Material Cellulose-fiber Cellulose-fiber Charge-modified, functionalized nonwoven Filter type Disc Disc Disc Charge Positive Positive Positive Filter layers Cross-sectional area 3.8 cm² 3.8 cm² 3.8 cm² Nominal pore size µm µm µm Used filter holder Ligaster 25 EXT Ligaster 25 EXT Ligaster 25 EXT Table 2: Virus models used for the virus clearance study Protein A Chromatography Low-pH Virus Inactivation X-MuLV MVM Family Retrovirus Parvovirus Size (nm) nm nm Lipid envelope Yes No Genome ssrna ssdna Physicochemical resistance Low Very high Rationale Representative nondefective C-type retrovirus Model for both human and animal parvoviruses Detector cell line PG-4 A9 For Personal Use Only Adsorptive Depth Filtration Polishing Step 1 Polishing Step 2 (if necessary) Virus Filtration Ultrafiltration/ Diafiltration conditions. We tested laboratoryscale modules of these 3M filter types: EXT, EXT, and the functionalized nonwoven (FNW) Emphaze anion-exchange (AEX) Hybrid Purifier. The chromatographic characteristic of the latter filter comes mainly from its comparably high content of positively charged quaternary groups captured within a non-woven matrix. For these downscale virus retention studies, we Table 3: Experiments carried out with all three depth filters ph 5.5 Low Salt ph 7.0 Low Salt used the mammalian viruses X-MuLV and MVM. ph 7.0 High Salt X-MuLV x x x MVM x x Materials and Methods For these adsorptive depth filtration studies, we used ÄKTA Explorer 10 systems with Unicorn software from GE Healthcare. All buffers were 0.2-µm filtered before use. Table 1 lists our adsorptive test filters with anionic exchange functionality. Load Material and Virus Assay: Rentschler scientists performed virusspiking experiments at Charles River Biologics Testing Solutions in Cologne, Germany, using X-MuLV and MVM as model viruses (Table 2). Challenge materials were prepared from processed MAb-containing harvest. Culture harvest was clarified using a 3M encapsulated 16EZA system with E16E01A60SP02A capsules ( m²), 0.2-µm filtered and purified using protein A affinity chromatography. Column elution was achieved using a phosphate citrate Tris buffer system, and the eluate was adjusted to ph 3.5 and diluted to a MAb concentration of 5 g/l. Before the adsorptive depth filtration runs, the protein solution was divided and each sample load adjusted to desired loading conditions (ph value and sodium chloride concentration) (Table 3). Those adjustments were made using a phosphate citrate 1 M Tris buffer and 4M NaCl solution, leading to a final MAb concentration of 3.75 g/l. To exclude influence of test items on cell growth or virus replication, Charles River Biologics Testing Solutions also performed cytotoxicity and viral interference assays. The same test facility also provided virus stock solutions and further analyzed samples using 50% tissue-culture infective dose (TCID 50 ) assays. The detection limit of such assays depends on the volume of sample that is incubated with indicator cells. Those cells were cultivated for a specific incubation period and inspected microscopically for virus-induced changes in their morphology. Experimental Methods: Viral clearance experiments were performed with the three adsorptive filter types using three different buffer conditions, each in duplicate (Table 3). Virusreduction factors of X-MuLV and MVM were determined for these conditions phosphate citrate Tris buffer at ph
3 For Personal Use Only 5.5 with 0 M NaCl ( ph 5.5 low salt ) phosphate citrate Tris buffer at ph 7.0 with 0 M NaCl ( ph 7.0 low salt ). Those buffers represent appropriate conditions for further processing in a MAb purification. Additionally, viral reduction of X-MuLV ( nm) was determined in a phosphate citrate Tris buffer at ph 7.0 with 1M NaCl ( ph 7.0 high salt ) to minimize ionic interactions between viruses and the adsorptive filter material. By subtracting the high-salt condition s virus LRV from that of the low-salt condition, we calculated the viral clearance related to adsorption. Because MVM (20 25 nm) is much smaller than the nominal pore size of these filter media ( µm for the VR series), no additional filtrations were run under high-salt conditions. We excluded the mechanical effects for retention of MVM. Duplicate filtrations were run in parallel with two chromatography systems, so 180 ml of the affinitypurified and conditioned MAb solutions were spiked with 5% (v/v) (9 ml) of nonconcentrated, ultracentrifuged, and prefiltered virus stock solution (0.45-µm filter for X-MuLV and 0.1-µm filter for MVM). After mixing, a sample was withdrawn from the spiked pool and immediately analyzed for the virus titer ( load sample ). For X-MuLV, a Table 4: X-MuLV clearance results for the three charged depth filters tested second load sample was stored until the end of the filtration ( hold sample ). MVM is known to be physicochemically resistant (1). Analysts loaded 220 L/m² filter area (84 ml) of the starting material at 158 L/m²/h (1 ml/min) to the equilibrated adsorptive depth filters. Subsequently, they flushed those filters with 63 L/m² (24 ml) equilibration buffer. At the end, they analyzed the total filtrate virus titer (both flow-through and flush, referred to herein as the filtrate sample ) and determined the titer of the drawn hold sample. They calculated virus log-reduction values as described in Equation 1: LRV = log (C V ) L L (C F V F ) [ ] in which C L = virus concentration of the load, V L = volume of the load, C F = virus concentration in the filtrate, and V F = volume of the filtrate. Results and Discussion From cytotoxicity and viral-interference assays performed by Charles River Biologics Testing Solutions (data not shown), we obtained confirmation that no test items influenced cell growth or virus replication. The analysts also determined suitable sample dilutions for performing the TCID 50 assays. Removal of X-MuLV: Under low-salt Filter Emphaze AEX FNW ph 5.5 and 0 M NaCl (low salt) Minimum reduction value (log 10 ) ) 5.84 ± ± ± ± ± ± 0.28 ) 7.59 ± ± ± 0.23 ) ph 7.0 and 0 M NaCl (low salt) Minimum reduction value (log 10 ) ) 5.14 ± ± ± ± ± ± 0.26 ) 7.35 ± ± ± ± 0.26 ) ph 7.0 and 1 M NaCl (high salt) Minimum reduction value (log 10 ) ) 2.89 ± ± ± ± ± ± 0.39 ) 7.41 ± ± ± 0.29 ) 4.46 ± ± ± ± ± ± 0.26 conditions at ph 5.5 and ph 7.0, we observed no positive indicator cells of X-MuLV (TCID 50 assay) in filtrate fractions from all three tested filters. Excellent virus removal was obtained, at least in the range of LRV (Table 4). By contrast, under high-salt conditions at ph 7.0, we determined virus removal of 1.2 LRV (Emphaze AEX FNW) and 2.7 LRV ( and ) filters. Because high-salt concentrations suppress electrostatic interactions, we used such conditions to investigate virus removal without attractive electrostatic interactions. The low value for the Emphaze AEX FNW filter shows no significant virus removal capacity at high-salt condition; the assay s standard deviation is ±1 LRV. The LRV difference between highand low-salt conditions can be traced back to virus adsorption on positivecharged filter media. To understand this adsorptive X-MuLV retention, we calculated a revised LRV with values obtained under high-salt conditions (ph 7.0) subtracted from the value under low-salt conditions (ph 7.0 and ph 5.5) (Table 5, Figure 2). Doing so provided values of LRV for the depth filters. The Emphaze AEX FNW filter showed revised LRVs that were still high at 4.7 and 4.0 (Table 5, Figure 2). So the main retention mechanism of X-MuLV on the latter at low ionic strength can be attributed to ionic adsorption. Revised LRVs were lower for Zeta Plus and because of the persistent retention (2.7 LRV) at high-salt concentration. That outcome is probably related to hydrophobic interactions and/or marginal mechanical retention. Previous viral clearance studies using 90ZA filters had already shown that hydrophobic interactions are involved in virus retention at high ionic strengths (6). That phenomenon can be explained by the net charge of X-MuLV, which is nearly zero at ph 7.0 because the heterogenic isoelectric point (pi) of its major capsid protein (p30) ranges from 6.1 to 6.6 (10). Additionally, the p30 protein has many hydrophobic amino acids, possibly presenting exposed
4 Figure 2: Revised log-reduction values for X-MuLV indicate virus clearance is based on anionic retention mechanisms. Revised Log 10 Reduction Value ph 7.0 ph ZA05 90ZA05 Emphaze AEX FMW Figure 3: Log-reduction values for MVM at ph 5.5 and ph 7.0 Log 10 Reduction Value ZA05 90ZA05 ph 7.0 ph 5.5 Emphaze AEX FMW For Personal Use Only Table 5: Revised log-reduction values for X-MuLV Filter hydrophobic moieties. A minor retention by size may be attributed to convective entrapment that occurs (even if a filter s pore size is larger than the virus) when viruses are transported to pores by convection but are unable to traverse them fully because of irregular internal structures (11). A further possible reason for LRVs of >1 in the presence of 1M NaCl is related to ionic strength, which is not sufficient to suppress entirely the positive zeta potential. Therefore, some positively charged spots inside the filter might lead to virus removal even at high NaCl concentrations. With each virus load, two filtration runs were performed in duplicate to provide one value for the load s total virus load and two values for the filtrates total virus load for each tested condition and filter. Reduction values (Equation 1), and a mean value were calculated. The measured total virus load of the filtrates is indicated with mathematical symbols for equal or less than ( ) where no virus positive cells were observed with the TCID 50 assay sample dilution. Emphaze AEX FNW ph 5.5 (clearance attributed to ionic adsorption at low-salt conditions) Mean value of revised reduction value 3.10 log log log log 4.81 log Revised reduction value 2.95 log log log log 10 ph 7.0 (clearance attributed to ionic adsorption at low-salt conditions) Mean value of revised reduction value 2.40 log log log 10 Revised (net) reduction value 2.25 log log log log log log 10 Revised reduction values are calculated by subtracting the means of the reduction values under low-salt conditions (ph 5.5 and ph 7.0) from the means of the reduction values under high-salt conditions (ph 7.0). In the presence of 1M NaCl, electrostatic interactions are widely suppressed independently from the ph value. Therefore, the LRV from the low-salt conditions at ph 5.5 also can be subtracted from the LRV of the highsalt concentration at ph 7.0. MVM Removal: We observed a very effective MVM removal ( LRV) for all three depth filters at ph 5.5 and a clearance of LRV at ph 7.0 (Table 6, Figure 3). The nominal pore sizes of all three filters are significantly larger (>0.2 µm) than the MVM virus (20 25 nm), so we believe that such virus-removal capacity is almost solely related to adsorptive retention (3, 12). The pi of MVM is about ph 5 (13). So at ph 7.0, the virus should be negatively charged, and at ph 5.5 it should be nearly free of net charge. The higher MVM retention at ph 5.5 indicates that attractive electrostatic effects may play a minor role. It has already been shown that viruses are more effectively removed if operational ph values are near their pi (6). To explain the mode of virus adsorption in more detail (proportion of ionic and hydrophobic interactions), additional studies can be performed with even higher salt concentrations and/or using organic compounds such as propylene glycol (PG) to suppress electrostatic and hydrophobic interactions. Such studies can improve understanding of the mechanisms responsible for virus retention. However, a detailed breakdown of adsorptive virus removal on a charged depth filter applied in an antibodypurification process that further includes ph virus inactivation and a nanofiltration (size exclusion) is unnecessary to evidence the orthogonality of those removal steps. With each virus load, our analysts performed two filtration runs in double determination, leading to one value for the load s total virus load and two values for the filtrates total virus load for each tested condition and filter. Reduction values (Equation 1) and mean values were calculated. Measured total virus load of the filtrates is indicated with mathematical symbols for equal or less than ( ) where no virus-positive cells were observed in the TCID 50 assay sample dilution. Highly Efficient Virus Removal We have demonstrated the capability of,, and Emphaze AEX Hybrid Purifier filters in a unit operation for
5 For Personal Use Only Table 6: MVM clearance results for the three depth filters tested Filter Emphaze AEX FNW ph 5.5 and 0 M NaCl (low salt) Mean value of reduction value 7.21 log log log 10 ) 6.88 ± ± 0.29 viral clearance of a MAb purification process. A protein A purified antibody solution was spiked with two routinely used mammalian model viruses (X-MuLV and MVM), and the downscale virus-retention study was performed under conventional process conditions. For X-MuLV clearance by and filters, values of LRV could be obtained at ph 5.5 and ph 7.0. We attributed LRVs in the range of to electrostatic retention mechanisms. The residual virus clearance is probably attributable to hydrophobic or mechanical interactions. The Emphaze AEX FNW filter removed X-MuLV with LRVs of at ph 5.5 and 7.0 (low ionic strength), so its high values of could be attributed to electrostatic retention. The small, nonenveloped MVM virus was reduced efficiently by all tested filters at ph 5.5, with LRVs of MVM clearance was less effective at ph 7.0 (LRV ~2.5). We found that and particularly the Emphaze AEX FNW adsorptive depth filters can be considered highly efficient virusremoval options under typical conditions in a MAb downstream process. Moreover, the excellent viral clearance potential of the Emphaze filter by adsorptive retention can be claimed as an orthogonal method for viral safety with the currently adopted virus-filtration step (size exclusion) and low-ph inactivation. The virus removal capability of these charged filters is complementary to other virus clearance 6.55 ± ± ± ± 0.32 ) 9.13 ± ± ± 0.29 ) 2.25 ± ± ± ± ± ± 0.26 ph 7.0 and 0 M NaCl (low salt) Mean value of reduction value 2.56 log log log 10 ) 2.56 ± ± ± ± ± 0.39 ) 8.65 ± ± ± 0.29 ) 6.09 ± ± ± ± ± 0.26 steps in downscale validation studies of a MAb process. Just as in validating an anion-exchange chromatography step, the viral-reduction capacity of a charged depth filter must be determined under actual process conditions. So it has to be done individually for specific processes, with different amounts of process-related impurities (HCPs, DNA). We have shown this virus removal capability for our model antibody process using appropriate buffers and conditions. The capability to cover the purpose of an anion-exchange polishing step with a positively charged depth filter will directly allow us to redesign our three chromatography-step MAb purification platform into a more efficient and economical two-step process while maintaining product purity, quality, and safety. Acknowledgments The authors thank Pia Reimann, Peter Koklitis, and Carsten Erdmann at 3M for their project support and review of this manuscript. References 1 Zhou JX, et al. Viral Clearance Using Disposable Systems in Monoclonal Antibody Commercial Downstream Processing. Biotechnol. Bioeng. 100(3) 2008: ICH Q5A (R1). Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. US Fed. Reg. 63(185) 1998: Bergmann K, et al. Design and Performance of Viral Clearance Studies. BioProcess Int. 4(10) 2006: Faude A, et al. Virus Removal By Simple Depth Filtration in a Two-Step Downstream Process for MAb Production (poster). Recovery Conference, Rostock, 2014; fileadmin/downloads/rentschler_poster_ Recovery_ pdf. 5 Wang M. VR Filters for Viral Reduction. BioProcess Int. 9(7) 2011: Zhou JX. Orthogonal Virus Clearance Applications in Monoclonal Antibody Production. Process Scale Purification of Antibodies. Gottschalk U, Ed. John Wiley & Sons: Hoboken, NJ, 2009; Revie D, et al. Novel Application Approaches to Obtain Maximum Viral Clearance from an Immunoglobulin Production Process. IBC s Second International Symposium on Viral Clearance, Application Brief. Cuno VR Filters for Viral Reduction in Blood Plasma Fractionation Processes. Cuno (3M): Meriden, CT, April 2002; mws/media/418846o/zeta-plus-vr-filters-viralreduction-blood-plasma-fractionation. pdf?fn=doc00042%20-%20 LITCABZPVR1.E.pdf. 9 Müller D, et al. Taking MAb Purification to the Next Level. Europ. Biotechnol. Life Sci. Ind. 13, 2014: Mitra S, et al. Comparative Physicochemical and Biological Properties of Two Strains of Kilham Rat Virus, a Non- Defective Parvovirus. J. Gen. Virol. 61(Pt l) 1982: Trilisky, et al. Flow-Dependent Entrapment of Large Bioparticles in Porous Process Media. Biotechnol. Bioeng. 104(1) 2009: Hou K, et al. Capture of Latex Beads, Bacteria, Endotoxin, and Viruses By Charge- Modified Filters. Appl. Environ. Microbiol. 40(5) 1980: Ray S, et al. Chapter 26: Single-Use Virus Clearance Technologies in Biopharmaceutical Manufacturing: Case Studies. Single-Use Technology in Biopharmaceutical Manufacture. Eibl R, Ed. John Wiley & Sons: Hoboken, NJ, 2011: Mario Metzger and Anja Gerster are process engineers in technology development; Marcus Peiker is process manager, Sabine Faust is a process engineer, and Alexander Faude is associate director of downstream process development; Sybille Ebert is assicate director, and corresponding author Dr. Dethardt Müller (dethardt.mueller@ rentschler.de) is vice president of technology development at Rentschler Biotechnologie GmbH in Laupheim, Germany. Dr. Sophie Winterfeld (swinterfeld@mmm.com) is senior engineer in application development for life sciences process technologies, and Nicole Mang is a senior sales account executive in life-science process technologies at 3M Deutschland GmbH in Neuss, Germany. Eprinted and posted with permission to 3M Corporation from BioProcess International February 2015 Informa.
6 For Personal Use Only
POROS HQ 50 and PI 50 resins in flow-through polish chromatography applications
APPLICATION NOTE POROS HQ 50 and PI 50 Resins POROS HQ 50 and PI 50 resins in flow-through polish chromatography applications Why and where to start? Introduction Anion exchange (AEX) chromatography products
More informationPolishing with membrane
B i op r o c e s s Technical Efficient Aggregate Removal from Impure Pharmaceutical Active Antibodies Sybille Ebert and Stefan Fischer-Frühholz Polishing with membrane chromatography (MC) has achieved
More informationAdsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
More informationBIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
More informationCapto adhere ImpRes. GE Healthcare Life Sciences. Polishing medium for MAb platform processes
GE Healthcare Life Sciences Data file 29-344-97 AA Multimodal chromatography Capto adhere ImpRes Capto adhere ImpRes is a BioProcess chromatography medium (resin) for high-resolution polishing of monoclonal
More informationPhenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
More informationNatriFlo HD-Q Data File
NatriFlo HD-Q Data File Executive Summary The NatriFlo HD-Q Membrane is an advanced material with a three-dimensional macroporous hydrogel structure that provides High Density of binding sites and rapid
More informationFiltration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
More informationMonoclonal Antibody Purification and Technology for Improving Virus Clearance
Monoclonal Antibody Purification and Technology for Improving Virus Clearance BioProcessing Network Annual Conference Brisbane, September 2009 Germano Coppola Technology Transfer Manager CSL Limited Outline
More informationThe Eshmuno Chromatography Family of Resins
The Eshmuno Chromatography Family of Resins The perfect accessory for highly productive downstream purification EMD Millipore is a division of Merck KGaA, Damstadt, Germany Introduction For over 300 years,
More informationViral Clearance Studies
Viral Clearance Studies viral clearance studies from the industry leader with unmatched experience and expertise Viral clearance is a critical component of regulatory submissions as it helps demonstrate
More informationModular Retrovirus Clearance in Support of Clinical Development
Modular Retrovirus Clearance in Support of Clinical Development Bio-product Research & Development, Eli Lilly and Company CMC Strategy Forum, Europe, 2018 D. Chen/ M. Murphy General Expectations for Viral
More informationDisposable devices for unit
D I S P O S A B L E S DOWNSTREAM Disposable Membrane Chromatography Performance Analysis and Economic Cost Model by Jeff Mora, Andrew Sinclair, Noushin Delmdahl, and Uwe Gottschalk Disposable devices for
More informationPhenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
More informationProcess Removal of Impurities in Biotech Products
Process Removal of Impurities in Biotech Products CASSS Midwest Regional Forum October 5, 2017 Warren R. Emery Sr. Research Scientist Bioproduct R&D, Eli Lilly and Company Pharmaceutical Process Development
More informationBioprocess streams using mammalian
Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration Barbara Tipton, Jeri Ann Boose, William Larsen, Joanne Beck, and Thomas O Brien Two types of depth
More informationThe practical task of monoclonal IgG purification with CHT TM ceramic hydroxyapatite
The practical task of monoclonal IgG purification with CHT TM ceramic hydroxyapatite Pete Gagnon, Jie He, Paul Ng, Julia Zhen, Cheryl Aberin, Heather Mekosh 11th Annual Waterside Conference, Chicago, May
More informationAn effective platform for purification of IgM monoclonal antibodies using Hydroxyapatite
An effective platform for purification of IgM monoclonal antibodies using Hydroxyapatite Frank Hensel, Patrys, GmbH Pete Gagnon, Validated Biosystems 5th International Conference on Hydroxyapatite and
More informationVirus Filtration for Biosimilars : From needs to Solutions
Virus Filtration for Biosimilars : From needs to Solutions 3 rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars - Hyderabad Tathagata Ray Layout of Presentation 1 Virus
More informationThe use of Chromatography Membranes for the development and production of biopharmaceuticals.
The use of Chromatography Membranes for the development and production of biopharmaceuticals. Dr. Juan Pablo Acosta Martinez Project Manager. Virus and Contaminant Clearance Sartorius Stedim Biotech Agenda
More informationRecent improvements in the use of CHT TM ceramic hydroxyapatite for removal of aggregates from monoclonal Antibodies
Recent improvements in the use of CHT TM ceramic hydroxyapatite for removal of aggregates from monoclonal Antibodies Pete Gagnon Validated Biosystems February 28, 2007 Why use CHT for MAb Purification?
More informationEuropean Guideline for Virus Safety Evaluation of Clinical Trial Material
Plasma Product Biotechnology Meeting, May 8 12, 2007 European Guideline for Virus Safety Evaluation of Clinical Trial Material Dr. Hannelore Willkommen Vice President Regulatory Affairs, NewLab Bioquality
More informationCUNO APPLICATION BRIEF
CUNO APPLICATION BRIEF CUNO Zeta Plus VR Filters for Viral Reduction in Biopharmaceutical Processes Introduction: The removal and/or inactivation to a high level of assurance of contaminating viruses from
More informationRisk Mitigation in Cell Culture: How to Prevent Viral Contamination
Platzhalter Bild Risk Mitigation in Cell Culture: How to Prevent Viral Contamination Upstream Day New Technology Platforms for Cell & Microbial Cultures May 2013 Claire Roulin, Application Specialist Purification
More informationApplication Note. Rapid optimisation and development of an automated two-step purification procedure for monoclonal IgG antibodies.
Rapid optimisation and development of an automated two-step purification procedure for monoclonal IgG antibodies Application Note ÄKTAFPLC Convenient and rapid standard purification protocol for monoclonal
More informationGORE. Protein Capture Devices. Operating Instructions Contents. Product Description Device Characteristics... 2 General Handling...
GORE Protein Capture Devices Operating Instructions Contents Product Description............................... 2 Device Characteristics............................. 2 General Handling................................
More informationSubject Index. chromatography step, 125-
A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, 144-168 Anion-exchange chromatography step for clinical-grade
More informationTable 1, Performance characteristics of Cellufine SPA-HC
SPA-HC An affinity chromatography resin designed for the isolation of immunoglobulins, including monoclonal antibodies (mab) from complex matrices, such as cell culture supernatant and serum/plasma. Cellufine
More informationProduction and Purification of Virus like particle (VLP) based Vaccine. Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative
Production and Purification of Virus like particle (VLP) based Vaccine Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative Outline 1 2 3 4 VLPs as Hepatitis C vaccines Baculovirus / insect cell
More informationDownsizing downstream processing: A novel single-use purification platform for biologics
Downsizing downstream processing: A novel single-use purification platform for biologics James Stout, PhD VP, Process Sciences BPI Boston, October 2015 Natrix Separations Inc. Burlington, Ontario, Canada
More informationSubject Index. See for options on how to legitimately share published articles.
Downloaded via 148.251.232.83 on March 27, 2019 at 03:59:27 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. A Alert limits, description, 70
More informationPractical Issues in the Industrial use of Hydroxyapatite for Purification of Monoclonal Antibodies
Practical Issues in the Industrial use of Hydroxyapatite for Purification of Monoclonal Antibodies Pete Gagnon, Validated Biosystems Inc., 240 Avenida Vista Montana Suite 7F, San Clemente, CA 92672 Paul
More informationA novel multimodal anion exchanger designed for monoclonal antibody purification
A novel multimodal anion exchanger designed for monoclonal antibody purification IBC s 18th International, Antibody Development &Production February-March, 2007 Hans J Johansson, Anders Ljunglöf, Kjell
More informationDownscaling Purification Processes for Biologics
Clearance Services Considerations in Downscaling Purification Processes for Biologics O-0280608 About BioReliance BioReliance Corporation is a leading provider of cost-effective contract services to the
More informationIntroduction to Size Exclusion Chromatography (SEC)
Introduction to Size Exclusion Chromatography (SEC) Sumalee Phumratanaprapin Channel Account Manager for BP, Indochina. Imagination at work 29166389AA July 2015 Content What is size exclusion chromatography
More information3M Emphaze. AEX Hybrid Purifier. 3M Innovation. Transform and Redefi ne. Effi ciency. Purity. Economics. 3M Purification
3M Purification SingleUse Hybrid Clarifier for Biopharmaceutical Processes 3M Emphaze AEX Hybrid Purifier 3M Innovation. Transform and Redefi ne. Effi ciency. Purity. Economics. 3M Emphaze AEX Hybrid Purifi
More informationGE Healthcare. Purification of monoclonal antibodies using modern chromatography media and membranes
GE Healthcare Purification of monoclonal antibodies using modern chromatography media and membranes Purification of monoclonal antibodies using modern chromatography media and membranes The use of monoclonal
More informationNonionic Polymer Enhancement of Aggregate Removal in Ion Exchange
Nonionic Polymer Enhancement of Aggregate Removal in Ion Exchange and Hydroxyapatite Chromatography Pete Gagnon, Richard Richieri, Simin Zaidi 12th Annual Waterside Conference, San Juan, Puerto Rico, April
More informationDinesh Khokal, PhD, Singapore
GaBI Educational Workshops 5 August 2018, Furama Resort Da Nang, Vietnam 1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS Dinesh Khokal, PhD, Singapore Director, External Affairs, Corporate
More informationJapanese Application Form: PMDA s Perspective on Manufacturing Process Description
Japanese Application Form: PMDA s Perspective on Manufacturing Process Description Reiko YANAGIHARA, Ph.D. Principal Reviewer Division of Pharmacopoeia and Standards for Drugs Office of Standards and Guideline
More informationSartobind IEX MA A Separation Technology Based on Macroporous Membranes
Operating Instructions Sartobind IEX MA 15 75 100 A Separation Technology Based on Macroporous Membranes 85032-539-13 Read operational instructions carefully before using Sartobind capsules.! Important
More informationCapacity and performance of MabSelect PrismA protein A chromatography resin
Capacity and performance of protein A chromatography resin is a protein A resin of which both the ligand and the base matrix have been optimized. The resin exhibits improved capacity over its predecessor
More informationSartobind TM Membrane Adsorbers Discs and Cassettes
85030-500-30 Sartobind TM Membrane Adsorbers Discs and Cassettes Reusable Sartobind Membrane Ion Exchangers for Adjustable Filter Holders (293 mm and 142 mm Ø) Contents Page 1. General Information 3 2.
More informationCenter for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA) PDA, Inc. 2014
Downloaded from journal.pda.org on May 13, 2018 Viral Clearance by Traditional Operations With Significant Knowledge Gaps (Session II): Cation Exchange Chromatography (CEX) and Detergent Inactivation George
More informationPolishing of monoclonal antibodies using Capto S ImpAct
Application note 29-83-27 AA Ion exchange chromatography Polishing of monoclonal antibodies using Capto S ImpAct Capto S ImpAct chromatography medium (resin) is a strong cation exchanger (CIEX). The medium
More informationEvaluation of novel CEX resin for continous processing of MAb purification
Engineering Conferences International ECI Digital Archives Integrated Continuous Biomanufacturing II Proceedings Fall 11-2-2015 Evaluation of novel CEX resin for continous processing of MAb purification
More informationDexS-HbP. Technical Note Heparin Mimetic Affinity. Model Protein adsorption to Cellufine MAX DexS-HbP resin
DexS-HbP A new chromatography resin incorporating a dextran sulfate polymeric ligand, acting as a Heparin mimetic for isolation and purification of plasma proteins Dextran sulfate is a synthetic derivative
More informationQ and S HyperCel Sorbents
Product Note USD 9 () Q and S HyperCel Sorbents High Productivity Ion Exchangers for Protein Capture and Separations Product Description and Application Overview Introduction Q and S HyperCel sorbents
More informationGiven paradigm shifts in the
B i o P r o c e s s TECHNICAL A Two-Step Purification Process Application of HIC Membrane Chromatography in a Disposable 2,000-L Clinical Facility Mukesh Mayani, Chittoor Narahari, Vivekh Ehamparanathan,
More informationHyperCel STAR AX Ion Exchange Sorbent
USD 2831(2) HyperCel STAR AX Ion Exchange Sorbent Salt Tolerant Advanced Recovery Anion Exchange Chromatography Sorbent An industry-scalable anion exchange chromatography sorbent designed for high productivity
More informationPATfix TM. Lead the way of your process
PATfix TM Lead the way of your process P A T f i x S O F T W A R E Short description incyght Chromatography Data Science Software Production of high value biological therapeutics usually involves complex
More informationHyperCel STAR AX Ion Exchange Sorbent
USD 28312a HyperCel STAR AX Ion Exchange Sorbent Salt Tolerant Advanced Recovery Anion Exchange Chromatography Sorbent An industry-scalable anion exchange chromatography sorbent designed for high productivity
More informationAVB Sepharose High Performance
GE Healthcare Life Sciences Data file 28-927-54 AB Custom designed media AVB Sepharose High Performance AVB Sepharose High Performance is an affinity chromatography medium (resin) designed for the purification
More informationTOYOPEARL GigaCap Series
TOYOPEARL GigaCap Series INTRODUCTION Ion Exchange Chromatography (IEC) is one of the most frequently used chromatographic modes for the separation and purification of biomolecules. Compared with other
More informationVivapure Virus Purification and Concentration Kits
Vivapure Virus Purification and Concentration Kits Fisher Scientific Fast and easy to use kits for virus purification Recombinant virus vectors are the preferred method for a wide range of gene delivery
More informationTools and solutions for separation of charged mab variants
GE Healthcare Tools and solutions for separation of charged mab variants A biosimilar is an almost identical version of an originator product, but to attain regulatory approval, a comparable quality to
More informationCase Studies of POROS Chromatography for Use in Vaccine and Large Biomolecule Purification
Case Studies of POROS Chromatography for Use in Vaccine and Large Biomolecule Purification Rev 1 (Life Tech template) Shelly Cote Parra April 2011 Topics Introduction to POROS Chromatography Products Principles,
More informationBioprocessing Challenges: High-Titer Mammalian-Based Cell Systems. Elements influencing the way Biologics may be manufactured /supplied in the future
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems Jonathan Romero CMC Leadership, Technical Development Pharmaceutical Operations & Technology 2015 ISPE PRODUCT SHOW Business Drivers Elements
More information1. Connect the column to the chromatography system, syringe or pump.
BabyBio TREN INSTRUCTIONS IN 45 655 030 The ready-to-use BabyBio TREN columns are prepacked with WorkBeads 40 TREN resin and are available in two column sizes, 1 ml and 5 ml. WorkBeads 40 TREN resin for
More informationPresented at the ECI Conference on Integrated Continuous Biomanufacturing Castelldefels, Spain, October 21, 2013
Continuous Antibody Capture with Protein A Countercurrent Tangential Chromatography: A New Column-Free Approach for Antibody Purification Andrew L. Zydney Department Head and Walter L. Robb Family Chair
More informationMonoclonal antibodies (mabs)
Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation Studies RONAN MCCARTHY, NICK HUTCHINSON, ISABELLE UETTWILLER, AMÉLIE BOULAIS, FRANÇOIS COUTARD, EVE DEPAW,
More informationSeparation of Monoclonal Antibodies Using TSKgel HPLC Columns
ANALYSIS S e p a r a t i o n R e p o r t N o. 7 4 Separation of Monoclonal Antibodies Using TSKgel HPLC Columns Table of Contents 1. Introduction 1 2. Separation Mode and Purification Method 1 3. Applications
More informationSimplicity is the key Continuous purification of monoclonal antibodies
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous Biomanufacturing Conference, Barcelona,
More informationBiologics derived from
SUPPLIER Side Advanced Viral Clearance Study Design A Total Viral Challenge Approach to Virus Filtration Michael Burnham, Alexander Schwartz, Esha Vyas, Nanna Takahashi, Pauline Nemitz, Daniel Strauss,
More informationTSK-GEL BioAssist Series Ion Exchange Columns
Separation Report No. 100 TSK-GEL BioAssist Series Ion Exchange Columns Table of Contents 1. Introduction 2 2. Basic Properties 2 2-1 Ion-Exchange Capacity and Pore Characteristics 2 2-2 Separation of
More informationThe monoclonal antibody (MAb) market
Reimagining Capacity for Today s Purification of Monoclonal Antibodies Jonathan Royce The monoclonal antibody (MAb) market has grown over the past decade to be about half of the biomanufacturing market
More informationChromatography column for therapeutic protein analysis
PRODUCT SPECIFICATIONS ProPac Elite WCX Column Chromatography column for therapeutic protein analysis Benefits Superior resolution power for proteins, monoclonal antibodies, and associated charge variants
More informationVirosart Media. Upstream Virus Retentive Filter. Product Information
Virosart Media Upstream Virus Retentive Filter Product Information Virosart Media is especially designed for virus filtration of chemically defined cell culture media. This high speed virus filter provides
More informationSartobind IEX nano 3 ml
Operating Instructions Sartobind IEX nano 3 ml A Separation Technology Based on Macroporous Membranes, 8 mm Bed Height 85032-536-01 Information Please read the operation instruction carefully before using
More informationThe Future of Viral Validation. Howard L. Levine, Ph.D. Process Validation for Biologicals Carlsbad, CA February 26 27, 2007
The Future of Viral Validation Howard L. Levine, Ph.D. Process Validation for Biologicals Carlsbad, CA February 26 27, 2007 Virus Safety Evaluation and Validation Increased scrutiny and requirements for
More informationFast protein separations with ion exchange columns
Fast protein separations with ion exchange columns Koji Nakamura*, Yoshio Kato and Shuichi Okuzono Nanyo Research Lab, Tosoh Corporation, 4560 Kaisei-cho, Shunan, Yamaguchi 746-8501, Japan TP106 0807 ISPPP-05
More informationIn the manufacture of monoclonal
B i o P r o c e s s TECHNICAL Author Insights Online Exclusive http://bit.ly/bpi-author-abs Characterization of Postcapture Impurity Removal Across an Adsorptive Depth Filter John Schreffler, Matthew Bailley,
More informationMonoclonal antibodies
V E N D O R Voice A Strategy for Developing a Monoclonal Antibody Purification Platform Anna Grönberg, Elin Monié, Maria Murby, Gustav Rodrigo, Elisabeth Wallby, and Hans J. Johansson Monoclonal antibodies
More informationCapture of mouse monoclonal antibodies
Capture of mouse monoclonal antibodies by cation exchange chromatography Life Science Products Processing Capture of mouse monoclonal antibodies from cell culture supernatant by cation exchange chromatography
More informationDynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors
Contact Us: www.pall.com/contact Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Dynamic High Capacity Mustang Q Membrane Units
More information3. Close the bottom end of the column and apply the packing device on top. Pump water through the upper adaptor to remove air.
INSTRUCTIONS FOR USE WorkBeads Protein A Product name Pack size Article number WorkBeads Protein A Bulk Media 1.5 ml 40605001 Bulk Media 5 ml 40605002 Bulk Media 10 ml 40605003 Bulk Media 100 ml 40605004
More informationGenetically engineered Adenovirus or Adeno-Associated Virus is used to infect logarithmically
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration Processes Applied in Viral Vector Based Gene Therapy Production Introduction Gene therapy involves the transfer of genetic
More informationPreparative Protein Chemistry
Biochemistry 412 Preparative Protein Chemistry 19 February 2008 The Three Eras of Protein Purification 1. The Classical (Pre-Recombinant DNA) Era (pre-1978) - Proteins purified from natural sources only
More informationAFFINITY HIS-TAG PURIFICATION
DESCRIPTION Nickel Affinity Cartridges 5ml are used for purification of histidine-tagged proteins in native or denaturing conditions. This cartridge can be used with an automated chromatography system,
More informationModular DSP approaches for complex non-mab molecules
Modular DSP approaches for complex non-mab molecules Dr. Stefan R. Schmidt MBA SVP Process Science & Production Agenda 1 Introduction 2 3 4 5 Process related impurities Product related impurities Virus
More informationIon exchange chromatography
Ion exchange chromatography Objectives: 1- The objective of this experiment is to learn the principles of ion exchange chromatography by separating the charged molecules using buffer and salt. 2- A practical
More informationINSECT CELL/BACULOVIRUS PRODUCTION
INSECT CELL/BACULOVIRUS PRODUCTION PEF # GENE NAME TRANSFER VECTOR BEVS MOLECULAR WEIGHT 2015-XXXX XXXX pbac1 flashbacultra TM 36.0 kda EXPRESSION METHOD OVERVIEW: Insect cells Spodoptera frugiperda (Sf9)
More informationCellufine MAX Q-r, Cellufine MAX Q-h
Operating Instructions Ion exchange Chromatography Media Cellufine MAX Q-r, Cellufine MAX Q-h Description Cellufine MAX is the new name of 2 nd generation Cellufine chromatography media. Cellufine MAX
More informationNovel Virus Clearance and Virus Detection Technologies and Applications
Novel Virus Clearance and Virus Detection Technologies and Applications Qi Chen, PhD Process Virology, Purification Development Genentech Inc., A Member of the Roche Group CMC Forum Japan December 3, 2018
More information3M Emphaze. AEX Hybrid Purifier. 3M Innovation. Transform and Redefi ne. Effi ciency. Purity. Economics. 3M Purification
3M Purification Single-Use Clarification and Purification for Biopharmaceutical Processes 3M Emphaze AEX Hybrid Purifier 3M Innovation. Transform and Redefi ne. Effi ciency. Purity. Economics. The 3M Emphaze
More informationChapter 6. Techniques of Protein and Nucleic Acid Purification
Chapter 6 Techniques of Protein and Nucleic Acid Purification Considerations in protein expression and purification Protein source Natural sources Recombinant sources Methods of lysis and solubilization
More informationPOROS CEX Slides: HS and XS
POROS CEX Slides: HS and XS April 2014 The world leader in serving science 1 Overview CEX introduction: POROS HS and XS There are lots of slides that have duplicate information. You will need to chose
More informationVivapure Ion Exchange Chromatography Products
croatia Vivapure Ion Exchange Chromatography Products turning science into solutions Vivapure Ion Exchange Protein Purification Products Chromatography gel beads (right) are shown on top of a membrane
More informationWorkBeads Protein A INSTRUCTIONS IN
WorkBeads Protein A INSTRUCTIONS IN 40 605 010 WorkBeads Protein A resin is designed for the purification of monoclonal and polyclonal antibodies using affinity chromatography. For small scale purification
More informationConference Summary: Gaps, Lessons Learned, and Areas for Improvement. K. Brorson, G. Miesegaes, O. Tounekti, et al.
Downloaded from on November 19, 2018 Conference Summary: Gaps, Lessons Learned, and Areas for Improvement K. Brorson, G. Miesegaes, O. Tounekti, et al. PDA J Pharm Sci and Tech 2014, 68 83-89 Access the
More informationPrimary Clarification Step Evaluation
Primary Clarification Step Evaluation Implementation of 3M Technologies During Transition to Late Stage Process Development Page 1 03/01/2017 / Mark Shannon, Development Scientist / BPI West 2017 Agenda
More informationBuilding the Vaccine Manufacturing Platforms of the Future: Disposable Manufacturing. Mats Lundgren, PhD GE Healthcare Life Sciences
Building the Vaccine Manufacturing Platforms of the Future: Disposable Manufacturing Mats Lundgren, PhD GE Healthcare Life Sciences Introduction 2 Why use disposables in vaccine production? Vaccines often
More informationApplication Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider
Combining small-scale purification and analysis of monoclonal antibodies on one instrument Protein purification with high-volume injection using the Agilent 126 Infinity Bio-inert Quaternary LC System
More information0E.03. profos AG. creative bioscience solutions. product information. creative bioscience solutions
0E.03 profos AG profos AG is a reliable and steadily growing biotechnology company. The combination of science, creativity and versatility under the paradigm of efficiency are our philosophy. Our products
More informationHigh-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography
High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography Agilent 1260 Infinity Bio-inert Quaternary LC System with Agilent Bio Columns
More information2 Liquid chromatography of biomolecules
2 Liquid chromatography of biomolecules Proteins, peptides, DNA, RNA, lipids, and organic cofactors have various characteristics such as electric charge, molecular weight, hydrophobicity, and surface relief.
More information1. Bloomsbury BBSRC Centre for Structural Biology, Birkbeck College and University College London.
Purification/Polishing of His-tagged proteins - Application of Centrifugal Vivapure Ion-exchange Membrane Devices to the Purification/Polishing of Histagged Background Multi-milligram quantities of highly
More informationDownstream Processing (DSP): Microscale Automation of Biopharmaceutical Processes. Michel Eppink, Synthon BV, Nijmegen, The Netherlands
Downstream Processing (DSP): Microscale Automation of Biopharmaceutical Processes Michel Eppink, Synthon BV, Nijmegen, The Netherlands Overview Introduction Why automation? Automation in DSP processes
More informationPurification strategies and platform alternatives for monoclonal antibodies
Purification strategies and platform alternatives for monoclonal antibodies Annika Forss, Anna Grönberg, Anders Ljunglöf, Karin Torstenson GE Healthcare Life Sciences, Björkgatan 30, SE-751 84 Uppsala,
More informationChallenges in Scaling Up Newly Developed Microbial Manufacturing Processes
Challenges in Scaling Up Newly Developed Microbial Manufacturing Processes Susan Dana Jones, Ph.D. BioProcess Technology Consultants BIO Process Zone Theater June 19, 2008 Microbial Process Development
More information